<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-molecules-25-02944">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Perricone</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Triggianese</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Bartoloni</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Cafaro</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bonifacio</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Bursi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Perricone</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gerli</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19</article-title>
  <source>J. Autoimmun.</source>
  <year>2020</year>
  <fpage>102468</fpage>
  <pub-id pub-id-type="doi">10.1016/j.jaut.2020.102468</pub-id>
  <pub-id pub-id-type="pmid">32317220</pub-id>
 </element-citation>
</ref>
